MedPath

四川智强医药科技开发有限公司

Ownership
-
Established
2004-07-23
Employees
-
Market Cap
-
Website
www.sczgyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

NMPA:10

Drug Approvals

Brimonidine Tartrate Eye Drops

Product Name
酒石酸溴莫尼定滴眼液
Approval Number
国药准字H20249428
Approval Date
Nov 22, 2024
NMPA

Lansoprazole Enteric-coated Capsules

Product Name
兰索拉唑肠溶胶囊
Approval Number
国药准字H20093522
Approval Date
Aug 23, 2023
NMPA

黄芪片

Approval Number
国药准字Z20090313
Approval Date
Aug 17, 2023
NMPA

Thioctic Acid Injection

Product Name
硫辛酸注射液
Approval Number
国药准字H20183110
Approval Date
Mar 22, 2023
NMPA

复方芦荟片

Approval Number
国药准字Z20080173
Approval Date
Jan 9, 2023
NMPA

Troxerutin and Sodium Chloride Injection

Product Name
曲克芦丁氯化钠注射液
Approval Number
国药准字H20041284
Approval Date
Sep 27, 2020
NMPA

柔肝解毒口服液

Approval Number
国药准字B20020559
Approval Date
May 29, 2020
NMPA

乳疾灵胶囊

Approval Number
国药准字Z20050454
Approval Date
May 29, 2020
NMPA

地榆升白胶囊

Approval Number
国药准字Z20150005
Approval Date
Dec 17, 2019
NMPA

Esomeprazole Sodium for Injection

Product Name
注射用艾司奥美拉唑钠
Approval Number
国药准字H20193290
Approval Date
Sep 29, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.